Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 45.00
Ask: 45.50
Change: -2.00 (-4.26%)
Spread: 0.50 (1.111%)
Open: 44.60
High: 45.30
Low: 44.50
Prev. Close: 47.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BMK08+CleanTreat Update

16 Apr 2021 11:00

RNS Number : 7421V
Benchmark Holdings PLC
16 April 2021
 

16 April 2021

 

Benchmark Holdings

("Benchmark" or the "Company")

 

BMK08+CleanTreatÒ Update

 

Ratification of Maximum Residue Limit under European Law

Significant milestone towards the commercialisation of BMK08 and CleanTreatÒ

 

Further to the notification made on 10 September 2020, Benchmark Holdings is pleased to announce that the MRL (Maximum Residue Limit) for its novel sea lice treatment BMK08 has now been ratified under European Law. The MRL confirms the safety of Benchmark's sea lice solution for consumers and represents a significant milestone in the regulatory approval process towards the anticipated commercial launch of BMK08 and CleanTreatÒ in Norway. The commercial launch remains subject to the grant of a Marketing Authorisation in Norway.

 

BMK08 and CleanTreatÒ is a transformational solution addressing the biggest biological challenge in salmon farming. The MRL EU ratification is the culmination of almost a decade of research and development, a rigorous trial programme and substantial capital investment by Benchmark.

 

Trond Williksen, CEO, commented:

 

"The ratification of the MRL is a further stepping stone towards commercialisation following the announcement of our first customer agreements for CleanTreatâ announced in March.

 

Sea lice continues to be the biggest biological challenge for salmon producers and Benchmark's novel solution addresses this challenge in a sustainable way both in terms of animal welfare and environmental impact."

 

Enquiries:

 

 

Benchmark Holdings plc

Tel: 020 3696 0630

Ivonne Cantu, Investor Relations Director

 

Rachel Aninakwah, Communications

 

 

 

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black / Freddie Barnfield / Duncan Monteith

 

 

 

MHP

 

Katie Hunt /Alistair de Kare-Silver

Tel: 020 3128 8742

benchmark@mhpc.com

 

 

 

 

 

About Benchmark 

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDKABNCBKKAQD
Date   Source Headline
20th Dec 20197:00 amRNSFull Year Results
4th Dec 20197:00 amRNSDirectorate Change
29th Nov 20197:00 amRNSQ4 and FY Trading Update & Notice of Results
29th Nov 20197:00 amRNSTotal Voting Rights
11th Nov 20197:00 amRNSChief Financial Officer Appointment Update
8th Nov 20197:00 amRNSInvesting in a sustainable future for aquaculture
31st Oct 20197:00 amRNSTotal Voting Rights
28th Oct 20197:00 amRNSUpdate on dissolution of JV with AquaChile
25th Oct 20198:10 amRNSHolding(s) in Company
25th Oct 20197:00 amRNSHolding(s) in Company
11th Oct 201911:15 amRNSDIRECTOR DEALINGS
30th Sep 20197:00 amRNSTotal Voting Rights
27th Sep 20197:00 amRNSDIRECTOR DEALINGS
20th Sep 20197:00 amRNSBlock listing Interim Review
17th Sep 20197:00 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSDIRECTOR DEALINGS
16th Sep 20197:00 amRNSDIRECTOR DEALINGS
12th Sep 20194:25 pmRNSHolding(s) in Company
12th Sep 201911:15 amRNSHolding(s) in Company
11th Sep 20197:00 amRNSUpdate on commercial licensing deals
30th Aug 20197:00 amRNSTotal Voting Rights
19th Aug 20197:00 amRNSDirectorate Change
16th Aug 20193:55 pmRNSDetails of Investor Call
14th Aug 20197:00 amRNSDirectorate Change
12th Aug 20197:00 amRNSQ3 Trading Update
31st Jul 20191:15 pmRNSReplacement: Total Voting Rights
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 20197:00 amRNSGenetics Breakthrough in Tilapia
9th Jul 20197:00 amRNSDirectorate Change
2nd Jul 20193:49 pmRNSHolding(s) in Company
2nd Jul 20197:00 amRNSHolding(s) in Company
28th Jun 20194:41 pmRNSSecond Price Monitoring Extn
28th Jun 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20192:05 pmRNSSecond Price Monitoring Extn
28th Jun 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSInterim Results
13th Jun 20198:00 amRNSPlacement of a new senior secured bond issue
10th Jun 20197:00 amRNSUpdate on Joint Venture with AquaChile
3rd Jun 20197:00 amRNSTrading Update and Investor Meetings
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSUpdate on Joint Venture with AquaChile
30th Apr 20197:00 amRNSTotal Voting Rights
29th Mar 20192:25 pmRNSReplacement: Total Voting Rights
29th Mar 20197:00 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Mar 201912:21 pmRNSResult of AGM
28th Feb 20197:00 amRNSTotal Voting Rights
20th Feb 20197:00 amRNSAppointment of Non-Executive Director
29th Jan 20193:07 pmRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.